Dermatologic immune-related adverse events associated with immune checkpoint inhibitors
A prospective real-world observational study in Switzerland.
Trösch A, Zahn CA, Cazzaniga S, Özdemir BC, Feldmeyer L, Benzaquen M
JAAD InternationalIn the feed 11 Jul 2026, published online 8 Jun 2026, issue 2026 Aug, added to PubMed 11 Jul 2026
Topics: Drug reactionsCancer drugs
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42434520 · DOI 10.1016/j.jdin.2026.05.023